Minesh P Mehta MD FASTRO

Radiation Oncology•Miami, FL

Central Nervous System Cancer, Thoracic Cancer

Professor and Chair, Radiation Oncology, School of Medicine, Florida International University

Request Appointment

8900 N Kendall Dr# MiamiMiami, FL 33176
Book by Phone+1(786) 791-2966
Fax+1 305-279-7778

Education & Training

University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1984 - 1988
University of Zambia, School of MedClass of 1981

Certifications & Licensure

MD State Medical License 2012 - 2027
WI State Medical License 1987 - 2027
CA State Medical License 2011 - 2026
FL State Medical License 2015 - 2026
IL State Medical License 1985 - 2026
OH State Medical License 2010 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2010, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2013
Top Doctors:Baltimore Area Castle Connolly, 2012

Clinical Trials

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma Start of enrollment: 1999 Feb 02
Completed
Phase 2
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
COMPLETED
PHASE2, PHASE3
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 06
Terminated
Phase 3
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Terminated
Phase 2
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Start of enrollment: 2006 Jan 01
Completed
Phase 3
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2010 Jul 01
Completed
Phase 2
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2011 Mar 01
Completed
Phase 2
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2014 Dec 04
ACTIVE_NOT_RECRUITING
PHASE2
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). Start of enrollment: 2016 Jul 01
Active, not recruiting
Phase 3
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia Start of enrollment: 2020 Aug 28
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Benchmarking Modern Day Pencil Beam Scanning Proton Therapy Treatment Times: Insights From Real Time Location Service Treatment Time Data.
Kristen McConnell, Andrew Wroe, Maria Valladares, Lorrie LeGrand, Ulrich Ramos
International Journal of Particle Therapy. 2025-12-01
Importance of 3D-TSE imaging for patients with brain metastasis treated with SRS alone.
Eyub Y Akdemir, Joseph DiStefano, Kevin J Abrams, Charif Sidani, Margaret C Chaneles
Radiotherapy and Oncology. 2025-12-01
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.
Vinai Gondi, Stephanie L Pugh, Minesh P Mehta, Jeffrey S Wefel, Wolfgang A Tomé
Journal of Clinical Oncology. 2025-11-10

Journal Articles

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
Kevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, Neurosurgery
Multi-Institutional External Validation of a Novel Glioblastoma Prognostic Nomogram Incorporating MGMT Methylation
Shahed N Badiyan, Minesh P Mehta, Yuan James Rao, Liam T Kane, Jason K Molitoris, Jiayi Huang, Journal of Neuro-Oncology

Press Mentions

Trial Analysis Shows Improvement in Survival Outcomes for Glioblastoma Patients Receiving Proton TherapyOctober 1st, 2025
NRG Oncology Trial Reveals Enhanced Survival in Glioblastoma Patients Treated with Proton Therapy, Advances to Phase IIISeptember 30th, 2025
Proton Therapy Dose Escalation May Improve Outcomes for Glioblastoma PatientsSeptember 29th, 2025
Join now to see all

Grant Support

Nabtc (Ucsf Project Leader) U Of WisconsinNational Cancer Institute1998–2008
Phase II Trial Of EMD 121974 For Recurrent GlioblastomaNational Center For Research Resources2007
Phase II Study Of Xrt + Low-Dose Temozolomide Followed By Temozolomide + CPT-11National Center For Research Resources2006–2007
Phase I/II Study Of OSI-774 And CCI-779 In Recurrent Malignant GliomaNational Center For Research Resources2006–2007
Phase I/II Trial Of CPT-11 And Temozolomide In Recurrent Malignant GliomaNational Center For Research Resources2004–2006
Phase I/II Trial Of R115777 In Patients With Recurrent Malignant GliomaNational Center For Research Resources2004–2005
Improving Cancer Outcome--Adaptive Helical TomotherapyNational Cancer Institute2001–2005
Phase I/II ZD1839 In Astrocytoma Or Glioblastoma And MeningiomaNational Center For Research Resources2004
Phase I/II OSI-774 In Recurrent Malignant Gliomas And Malignant Gliomas Post XrtNational Center For Research Resources2004
Phase I Study Of Zd 1839 And Temozolomide For The Treatment Of GliomasNational Center For Research Resources2004
Tomotherapy Based On Functional MRINational Cancer Institute2001–2002
Tomotherapy Based Dose PER Fraction Escalation In NsclcNational Cancer Institute2001–2002
Phase II Trial Of Thymidine &Carboplatin For Recurrent Malignant GLINational Center For Research Resources1999–2002
Phase Ib/Ii Trial Of PC 0120as Radiosensitizer In Metastatic Brain CancerNational Center For Research Resources1998–2002
Trial Of Irinotecan In PTS W Recurrent Malignant GliomaNational Center For Research Resources2000
Gadolinium Texaphyrin (Pci-0120) Radiation Sensitizer In Whole Brain Radiation THNational Center For Research Resources2000
Therapeutic Studies Of Primary CNS MalignanciesNational Cancer Institute1994–1997

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment